Item 11. Other Business Chair: Excellencies, distinguished delegates, ladies and gentlemen. We will now resume from where we had closed the session before lunch by adopting L10 and we will now proceed to the consideration of L6 rev. 1 as amended by L10. Is the commission ready to adopt L6 rev 1 as amended …
From Plenary Sessions
Plenary – Friday morning session
CND Chair. Today is the last day of our deliberations. Before we start, it’s wonderful to see you all here again. We had 4 days of productive, engaging discussions, wide-ranging conversations on a wide range of issues. We heard from CSOs and other stakeholders, and you had productive and meaningful deliberations. I will only make …
Plenary – Thursday afternoon session
Item 9. Contributions by the Commission to the work of the Economic and Social Council, including follow-up to and review and implementation of the 2030 Agenda for Sustainable Development Secretary: As you were saying, Mr. Chair, the ECOSOC coordination session was held in february and we supported the chair of the CND in his presentation …
Plenary – Thursday morning session
Item 6. Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem (continued) United States: The US takes the floor to address statements made yesterday regarding the mandate of the INCB which we do not …
Plenary — Wednesday afternoon session
Youth Forum: Your excellencies, distinguished delegates, ladies and gentleman. From 25 countries we gather as a unified voice to address the issue of substance use in our communities. This is not a new challenge and has been tackled over the past decades. Everyday there are new substances threatening individuals and society as a whole. It …
Plenary — Wednesday morning session
Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …